Publisher
Springer Nature Singapore
Reference78 articles.
1. Aapro M, Krendyukov A, Schiestl M, Gascón P (2018) Epoetin Biosimilars in the treatment of chemotherapy-induced anemia: 10 years’ experience gained. BioDrugs 32(2):129–135
2. American Cancer Society (n.d.) 9525.00.pdf. What Are Biosimilar Drugs? | Biosimilar Drugs for Cancer Treatment | American Cancer Society
3. Annex I (1999) Summary of product characteristics. Committee for Proprietary Medicinal Products The European Public Assessment Report (EPAR) Stocrin The European Agency for the Evaluation of Medicinal Products London
4. Antonelou M, Abro A, Heath R, Iacovou A, Ashley C, Caplan J et al (2022) Comparison of outcomes using the rituximab originator MabThera with the biosimilar Truxima in patients with ANCA-associated vasculitis. Scand J Rheumatol 51(2):135–141
5. Arip M, Tan LF, Jayaraj R, Abdullah M, Rajagopal M, Selvaraja M (2022) Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review. Discov Onc 13(1):91